Black and Hispanic living kidney donors are at increased relative risk for hypertension, diabetes requiring drug therapy, and CKD compared with their white counterparts, according to researchers.

The target BP level of less than 130/80 mm Hg for CKD patients—which is recommended by a Kidney Disease Outcomes Quality Initiative guideline—is not definitively supported by scientific data and could potentially lead to adverse effects, according to Julia B. Lewis, MD, of the division of nephrology and hypertension at Vanderbilt University School of Medicine in Nashville.

Low socioeconomic status (SES) increases blacks' risk of developing CKD nearly twofold, but does not increase the risk in whites, according to a recent report in the American Journal of Kidney Diseases (2010;55:977-980).

A high resting heart rate and low beat-to-beat heart rate variability raises the odds of developing kidney disease, according to a study that examined data from 13,241 participants in the Atherosclerosis Risk in Communities study.

C-reactive protein (CRP) predicts development of proteinuria in a screened cohort, according to Japanese researchers.

A study of patients seeking care at an inner-city clinic showed that higher levels of alkaline phosphatase and phosphate are associated with increased mortality.

Patients with both heart disease and CKD experience decreased risk of cardiovascular events.

Higher serum uric acid (SUA) levels may independently contribute to the development of CKD, data suggest.

Kidney disease is present in nearly one third of patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and it is a strong independent predictor of subsequent mortality, new findings show.

Mean net dietary phosphorus absorption is significantly lower after a single dose of lanthanum carbonate (LC) than after a single dose of sevelamer carbonate (SC), data suggest.